Date Title Description PDF
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download
21 Feb 2023 On business and financial situation The company releases the Integrated Report for the year 2022 Download
21 Feb 2023 About Corporate Governance The Company informs about the agreements adopted by the Board of Directors Download

Pages

Date Title Description PDF
21 May 2024 Announcement of general shareholders’ meeting Publication of the announcement of the call to the General Shareholders’ Meeting and the documentation related thereto.   Download
17 May 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 10 May and 16 May 2024 Download
10 May 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 2 May and 9 May 2024 Download
08 May 2024 Announcement of General Shareholders’ Meeting The Company announces the decision of its Board of Directors to convene the Ordinary General Shareholders' Meeting Download
30 Apr 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 26 April and 30 April 2024 Download

Pages

Date Title Description PDF
24 Feb 2016 Informe anual de remuneraciones de los consejeros 2015 ROVI releases the 2015 annual report regarding remuneration of the members of the Board of Directors Download
23 Dec 2015 Otros sobre operaciones corporativas Download
21 Dec 2015 Otros sobre operaciones corporativas Download
01 Dec 2015 Otros sobre gobierno corporativo Download
01 Dec 2015 Otros sobre Gobierno Corporativo (2) Download

Pages